top of page

Publications

Anti-tumor activity of a T-helper 1 multiantigen vaccine in a murine model of prostate cancer

Antigen Discovery & Vaccines

2022

Authors:

Cecil, D.L., Curtis, B, Gad, E., Gormley, M, Timms, A.E., Corulli, L., Bos, R., Damle, R.N., Sepulveda, M.A., and Disis, M.L.

Journal:

Scientific Reports

Volume:

12

Page:

13618

Pubmed:

Review Article

Vaccine Therapies for Cancer: Then and Now

Antigen Discovery & Vaccines

2021

Authors:

Morse, MA, Gwin, WR 3rd, and Mitchell, DA

Journal:

Targeted Oncology

Volume:

16(2)

Page:

121-152

Pubmed:

Original Article

Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways

Antigen Discovery & Vaccines

2021

Authors:

Cecil, D., Park, K H, Curtis, B, Corulli, L, and Disis, ML

Journal:

Journal for Immunotherapy of Cancer

Volume:

9

Page:

Pubmed:

Original Article

Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets

Antigen Discovery & Vaccines

2019

Authors:

Stanton SE, Gad E, Corulli LR, Lu H, Disis ML.

Journal:

Vaccine

Volume:

37(27)

Page:

3552-3561

Pubmed:

Review Article

Next generation approaches for tumor vaccination

Antigen Discovery & Vaccines

2017

Authors:

Patel A, Kaufman HL, Disis ML.

Journal:

Chinese Clinical Oncology

Volume:

6(2)

Page:

19

Pubmed:

Review Article

Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer

Antigen Discovery & Vaccines

2017

Authors:

Watt WC, Cecil DL, Disis ML.

Journal:

Seminars in Immunopathology

Volume:

39(3)

Page:

245-253

Pubmed:

Original Article

Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells In Vivo

Antigen Discovery & Vaccines

2017

Authors:

Cecil DL, Slota M, O'Meara MM, Curtis BC, Gad E, Dang Y, Herendeen D, Rastetter L, Disis ML.

Journal:

Clinical Cancer Research

Volume:

23(13)

Page:

3396-3404

Pubmed:

Original Article

Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer

Antigen Discovery & Vaccines

2016

Authors:

Ebben JD, Lubet RA, Gad E, Disis ML, You M.

Journal:

Molecular Carcinogensis

Volume:

55(11)

Page:

1517-1525

Pubmed:

Review Article

The Human Vaccines Project: A roadmap for cancer vaccine development

Antigen Discovery & Vaccines

2016

Authors:

Romero P, Banchereau J, Bhardwaj N, Cockett M, Disis ML, Dranoff G, Gilboa E, Hammond SA, Hershberg R, Korman AJ, Kvistborg P, Melief C, Mellman I, Palucka AK, Redchenko I, Robins H, Sallusto F, Schenkelberg T, Schoenberger S, Sosman J, Türeci Ö, Van den Eynde B, Koff W, Coukos G.

Journal:

Science Translational Medicine

Volume:

8(334)

Page:

8(334)

Pubmed:

Review Article

Current methods of epitope identification for cancer vaccine design

Antigen Discovery & Vaccines

2015

Authors:

Cherryholmes GA, Stanton SE, Disis ML.

Journal:

Vaccine

Volume:

33(51)

Page:

7408-7414

Pubmed:

bottom of page